Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	62.86	-4.94	-13.31
Graham Fair Price	41.42	0.22	0.15
PEG	-69.61	-0.03	0.09
Price/Book	-12.64	0.25	0.29
Price/Cash Flow	55.74	-5.34	-12.07
Prices/Earnings	56.32	-2.75	-6.29
Price/Sales	-56.32	1.13	2.59
Price/FCF	55.74	-5.34	-12.07
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-54.74	< 0.005	0.02
Operating Margin	-1.08	-0.13	-0.13
ROA	-100.00	-0.02	-0.01
ROE	-0.01	-0.02	-100.00
ROIC	-0.02	-0.02	-28.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	1.81	-0.69	160.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.76	-1.02	34.83
EPS QOQ	0.68	-0.97	43.72
FCF QOQ	-1.29	-0.97	24.82
Revenue QOQ	-0.82	1.00	22.45
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1.33	-0.66	50.55
Days Sales Outstanding (DSO)	280.08	280.76	0.24
Inventory Turnover	-67.60	-136.71	-102.24
Debt/Capitalization	< 0.005	< 0.005	179.55
Quick Ratio	6.49	11.23	72.93
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.30	0.30	0.00
Cash	0.04	0.05	6.65
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.01	-97.35
Revenue	0.03	0.07	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	13.73	13.73	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.82	6.78	-42.63
Naive Interpretation	Member

06 - Financial Health · Bad

Rating